Skip to main content
Livermore
Livermore
ZHEN

WP Advisors, LLC

SEC CIK
0001697796
Latest filing
Jul 29, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by WP Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
1,205
Value
$751.5K
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of REGN by WP Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,205$751.5K0.2%−282−19.0%ReducedHolders
Q1 20261,487$1.15M0.3%−79−5.0%ReducedHolders
Q4 20251,566$1.21M0.3%−434−21.7%ReducedHolders
Q3 20252,000$1.12M0.3%−96−4.6%ReducedHolders
Q2 20252,096$1.10M0.3%+3+0.1%AddedHolders
Q1 20252,093$1.33M0.4%−138−6.2%ReducedHolders
Q4 20242,231$1.59M0.5%−102−4.4%ReducedHolders
Q3 20242,333$2.45M0.9%−278−10.6%ReducedHolders
Q2 20242,611$2.74M0.9%−165−5.9%ReducedHolders
Q1 20242,776$2.67M0.9%−40−1.4%ReducedHolders
Q4 20232,816$2.47M0.9%−25−0.9%ReducedHolders
Q3 20232,841$2.34M1.0%−20−0.7%ReducedHolders
Q2 20232,861$2.06M0.8%−92−3.1%ReducedHolders
Q1 20232,953$2.43M1.0%00.0%UnchangedHolders
Q4 20222,953$2.13M1.0%−53−1.8%ReducedHolders
Q3 20223,006$2.07M0.9%00.0%UnchangedHolders
Q2 20223,006$1.78M0.8%−49−1.6%ReducedHolders
Q1 20223,055$2.13M0.9%−110−3.5%ReducedHolders
Q4 20213,165$2.00M0.8%00.0%UnchangedHolders
Q3 20213,165$1.92M0.8%−30−0.9%ReducedHolders
Q2 20213,195$1.78M0.7%+181+6.0%AddedHolders
Q1 20213,014$1.43M0.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.